Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by ferdie1on Apr 10, 2011 7:26pm
213 Views
Post# 18411381

RE: RE: Another Buy Signal for BRD - TURN AROUND?

RE: RE: Another Buy Signal for BRD - TURN AROUND?Stanley

Future is much determined by the past, if you can "educate" yourself with the ore body there you might sound you know of what you speak, 2 grams/tonne ug does not make a mine, so by highgrading all the 4 gram? That was all they had, they had some upper zones in the carb at 150 level where the dd holes were 10m apart and they still couldn't follow the "vein". There is no vein in the carb zone, should they DD every 3m, will it be economical?

You speak of SAS stealing the gold, they didnt have to, it wasn't there, they take many samples along the way to ensure they have proper reconciliation. Don't spin a story thats not there. Now that they have the first stope out from the u/g and the pit is blasting ore again lets see the 2nd quarter stats when they come out, no more excuses WD this company has to perform to make us non-believers (bashers) believe.

Time will tell gents..time will tell.






Bullboard Posts